There is a need to screen and treat sexual dysfunction disorders among patients with IBD. Patients with inflammatory bowel disease (IBD), especially women, have a high prevalence of sexual dysfunction ...

Among individuals without a history of mental illness, semaglutide for weight management is not associated with an increased risk for suicidality or depressive symptoms, according to study results ...

Patient education could help clarify that remission in inflammatory bowel disease does not solely consist of resolved symptoms.

COVID-19 has no impact on body mass index (BMI) trajectory or lung function in people with cystic fibrosis (pwCF) in the year following infection.

Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...

Immunosuppressive therapy may help reduce gastrointestinal symptoms among patients with systemic sclerosis. Immunosuppressive therapy may help reduce gastrointestinal (GI) symptoms among patients with ...

Insulin resistance (IR) is associated with multiple systemic diseases, according to a study presented at the annual meeting of the European Association for the Study of Diabetes.

Empagliflozin confers kidney-protective benefits for patients with acute myocardial infarction (MI) and an increased risk for heart failure.

MASLD prevalence and liver-related mortality vary across the world due to clinic demographic and food insecurity.

An association exists between leisure-time sedentary behavior and risk for CVD in patients with metabolic dysfunction-associated fatty liver disease.

Food consumption, particularly of oats and fruits, was associated with an increased risk for type 1 diabetes among genetically predisposed children.

Pouchitis risk among individuals with Crohn disease-like pouch inflammation decreases with endoscopic response.